PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

PharmaShots' Key Highlights of Second Quarter 2022

PharmaShots' Key Highlights of Second Quarter 2022

June 30, 2022

AstraZeneca Reports Results of Imfinzi in P-III (AEGEAN) Trial for the Treatment of Non-Small Cell Lung Cancer

AstraZeneca Reports Results of Imfinzi in P-III (AEGEAN) Trial for the Treatment of Non-Small Cell Lung Cancer

June 30, 2022

Astellas Entered into an Exclusive License Agreement with Generian to Develop and Commercialize Novel Small Molecules for Undruggable Indications

Astellas Entered into an Exclusive License Agreement with Generian to Develop and Commercialize Novel Small Molecules for Undrugga...

June 30, 2022

Ascentage Reports the US FDA’s Acceptance of IND Application for APG-5918 to Treat Solid Tumors and Hematologic Malignancies

Ascentage Reports the US FDA’s Acceptance of IND Application for APG-5918 to Treat Solid Tumors and Hematologic Malignancies

June 30, 2022

GBT Reports Initiation of the P-II/III Study of GBT601 for the Treatment of Sickle Cell Disease

GBT Reports Initiation of the P-II/III Study of GBT601 for the Treatment of Sickle Cell Disease

June 30, 2022

Merck Reports the Launch of Merck Digital Sciences Studio to Support Early-Stage Biomedical Startups

Merck Reports the Launch of Merck Digital Sciences Studio to Support Early-Stage Biomedical Startups

June 30, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us